Stance Capital’s Thermo Fisher Scientific TMO Stock Holding History

Stance Capital’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,405	Closed	-$1.39M	–	319
2025 Q4	$1.39M	Sell	2,405 -398	-14%	-$225K	0.51%	74
2025 Q3	$1.36M	Sell	2,803 -426	-13%	-$198K	0.5%	84
2025 Q2	$1.31M	Buy	+3,229	New	+$1.35M	0.49%	112
2025 Q1	–	Sell	-351	Closed	-$183K	–	247
2024 Q4	$183K	Buy	+351	New	+$193K	0.11%	82

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Stance Capital's TMO Position: Q1 2026 in Review

Stance Capital sold out of Thermo Fisher Scientific (TMO) in Q1 2026, closing a stake of 2,405 shares — an estimated $1.39M sold.

Stance Capital first reported a position in TMO in Q4 2024 and held it in 4 quarters. The position peaked at $1.39M in Q4 2025. 2,589 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

Stance Capital reported no remaining Thermo Fisher Scientific position as of Q1 2026 after selling out during the quarter.
Stance Capital sold 2,405 Thermo Fisher Scientific shares in Q1 2026, an estimated $1.39M.
Stance Capital first reported a position in Thermo Fisher Scientific in Q4 2024 and held it in 4 quarters.
Stance Capital's Thermo Fisher Scientific position peaked at $1.39M in Q4 2025.
2,589 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Stance Capital's 13F filing for Q1 2026, filed 14 May 2026.